BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Arjuna A, Olson MT, Walia R, Bremner RM, Smith MA, Mohanakumar T. An update on current treatment strategies for managing bronchiolitis obliterans syndrome after lung transplantation. Expert Rev Respir Med 2021;15:339-50. [PMID: 33054424 DOI: 10.1080/17476348.2021.1835475] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
Number Citing Articles
1 Arjuna A, Olson MT, Walia R. Current trends in candidate selection, contraindications, and indications for lung transplantation. J Thorac Dis 2021;13:6514-27. [PMID: 34992831 DOI: 10.21037/jtd-2021-09] [Reference Citation Analysis]
2 Olson MT, Liu W, Mohanakumar T, Bremner RM. A potential mechanism by which aspiration of duodenogastric fluid augments the risk for bronchiolitis obliterans syndrome after lung transplantation. J Thorac Cardiovasc Surg 2022:S0022-5223(22)00342-7. [PMID: 35428458 DOI: 10.1016/j.jtcvs.2022.03.009] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Shu P, Zhang W, Zhang Y, Zhao Y, Li Y, Zhang X. Interleukin-18: A Novel Participant in the Occurrence, Development, and Drug Therapy of Obliterative Bronchiolitis Postlung Transplantation. Dis Markers 2021;2021:5586312. [PMID: 34367377 DOI: 10.1155/2021/5586312] [Reference Citation Analysis]